CBD Is Not Yet a Proven or Standardized Treatment for Muscle Spasms
Muscle spasms can be painful, disruptive, and difficult to treat. Although cannabidiol (CBD) is widely promoted as a natural option, there is no well-established CBD dose or schedule for treating muscle spasms in general. The best available evidence applies mainly to spasticity associated with multiple sclerosis and involves specific cannabis-based medicines—not necessarily over-the-counter CBD oils, creams, or gummies.
What the research shows
A 2023 randomized, placebo-controlled trial evaluated THC, CBD, and a combination of the two in adults with multiple sclerosis or spinal-cord injury. The study found no significant improvement in pain or spasticity with CBD alone, THC alone, or the combination over six weeks. The trial was smaller than planned, so its results do not rule out benefits for every patient, but they do not support a reliable CBD dosing formula for muscle spasms.
Some evidence supports a different product: nabiximols, an oromucosal spray containing approximately equal amounts of THC and CBD. A 2022 Cochrane review found that nabiximols probably reduces self-reported spasticity in people with multiple sclerosis over the short term. The evidence was less convincing when spasticity was measured with objective clinical tests, and side effects sometimes led participants to stop treatment.
These findings should not be interpreted as proof that CBD products treat all types of muscle spasms. Spasms may result from dehydration, medication effects, nerve disorders, spinal-cord injury, multiple sclerosis, muscle overuse, or other conditions. Treating the underlying cause is often more important than selecting a supplement.
CBD administration methods
Oral or sublingual products
CBD oils and tinctures are commonly placed under the tongue or swallowed. Absorption and the time required for effects can vary substantially depending on the product, formulation, dose, food intake, and individual metabolism. A dropper may make it easier to measure a product, but measurement does not guarantee that the labeled amount is accurate or that a particular dose will relieve spasms.
Oral CBD produces effects throughout the body and may also increase the risk of interactions with prescription medicines. The FDA-approved CBD medicine Epidiolex is authorized for certain seizure disorders, not muscle spasms. Its dosing instructions should not be used to calculate a dose for spasticity or for an over-the-counter CBD product.
Topical products
CBD creams, lotions, and balms are applied to the skin over an affected area. They may feel soothing, particularly when massage, heat, or other ingredients are also involved, but evidence that topical CBD relieves muscle spasms is limited. Because topical products are not standardized and may have variable absorption, there is no validated topical dose or frequency for this purpose.
Topical use may involve less whole-body exposure than an oral product, but it is not automatically risk-free. Products can contain other active ingredients, and skin irritation or allergic reactions are possible. Claims that a topical product reliably reaches deep muscle tissue or produces a specific therapeutic effect should be viewed cautiously unless supported by clinical research.
How to approach CBD safely
People who nevertheless choose to try CBD should discuss it with a healthcare professional, especially if they take prescription medicines, have liver disease, are pregnant or breastfeeding, or are treating spasms caused by a neurological condition. The Food and Drug Administration warns that CBD can cause liver injury, interact with other medicines, and produce side effects such as sleepiness, diarrhea, and changes in alertness.
There is also a quality-control problem. Unlike approved prescription medicines, many nonprescription CBD products have not undergone the same testing for consistency, purity, and effectiveness. The National Center for Complementary and Integrative Health notes that some products contain more or less CBD than their labels indicate and may contain contaminants, including THC.
If a clinician agrees that a trial is reasonable, a cautious plan should use one product at a time, follow the product label, avoid combining CBD with alcohol or other sedating substances, and monitor for drowsiness, dizziness, gastrointestinal symptoms, mood changes, or other adverse effects. Increasing the dose repeatedly without medical guidance is not a reliable way to improve results.
The bottom line
CBD may be of interest to people seeking relief from muscle spasms, but current evidence does not establish a standard dose, frequency, or administration method for general muscle-spasm treatment. The clearest evidence concerns selected cannabis-based medicines—particularly nabiximols—for self-reported spasticity in multiple sclerosis, not CBD products sold directly to consumers.
Persistent, severe, or unexplained spasms should be evaluated medically. A healthcare professional can identify the cause, review established treatments, and determine whether any cannabinoid product can be considered safely alongside—not instead of—appropriate care.
